Keywords: ARV, antiretroviral; CADR, cutaneous adverse drug reaction; HIV; LP, lichen planus; TMP-SMX, trimethoprim-sulfamethoxazole; antiretroviral therapy; drug; efavirenz; lichenoid eruption.